Reumatolog Khurram Ashraf ApS: Financial statements 2019
CVR: 39336081
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
Reumatolog Khurram Ashraf ApS (CVR 39336081) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 165,474 and a net result of DKK 127,672 compared with DKK 36,913 the year before. That is an increase of 244% compared with the year before. Equity in the 2019 report amounted to DKK 164,586. The solvency ratio was 73.3%.
- Gross Profit
- DKK 165,474
- Profit/Loss
- DKK 127,672
- Equity
- DKK 164,586
- Total Assets
- DKK 224,388
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
On November 18, 2019, the company changed its name from Reumatolog Khurram Ashraf IVS to Reumatolog Khurram Ashraf ApS.
Reumatolog Khurram Ashraf ApS has published its annual report for 2018. Gross profit came to DKK 48,108, and the net result was DKK 36,913.
About Reumatolog Khurram Ashraf ApS
Reumatolog Khurram Ashraf ApS is a Danish company of the type Anpartsselskab based in Hillerød, founded in 2018. The company is registered under the industry Alment praktiserende lægers aktiviteter. The company was previously named Reumatolog Khurram Ashraf IVS. The management consists of Khurram Ashraf. The company is owned by Speciallægen FZJ Holding ApS. The company has 5 employees (2026). In 2025, the company reported a gross profit of DKK 633,663 and a net result of DKK 130,666 compared with DKK 46,332 the year before. Equity in the 2025 report amounted to DKK 52,832.
